Enrichment of mutant calmodulin protein in a murine model of a human calmodulinopathy

Wen-Chin Tsai1,2, Chiu-Fen Yang1,3, Shu-Yu Lin3,4

  • 1Department of Cardiology, Cardiovascular Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

JCI Insight
|July 24, 2025
PubMed

Insights

Calmodulinopathy hearts accumulate high levels of mutant calmodulin (CALM) protein, exceeding wildtype levels. This increased mutant CALM protein, due to reduced degradation, correlates with arrhythmia severity.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Biochemistry

Background:

  • Missense mutations in calmodulin (CALM)-encoding genes cause life-threatening arrhythmias.
  • The precise levels of wildtype versus mutant CALM protein in affected hearts are unknown.

Purpose of the Study:

  • To quantify mutant and wildtype CALM transcript and protein levels in mice with a p.N98S mutation in the Calm1 gene.
  • To investigate the relationship between mutant CALM protein levels and the resulting electrophysiological phenotype.

Main Methods:

  • Quantitative analysis of CALM transcript and protein levels in knock-in mouse hearts.
  • Assessment of electrophysiological phenotypes in heterozygous and homozygous mutant mice.

Main Results:

  • Mutant CALM transcripts were less abundant than wildtype transcripts.
  • Mutant CALM protein levels increased in a dosage-dependent manner, surpassing wildtype levels.
  • Higher mutant-to-wildtype CALM protein ratios correlated with increased arrhythmia severity.
  • Reduced N98S-CALM protein degradation contributed to its accumulation.

Conclusions:

  • Calmodulinopathy can arise from a single CALM gene mutation through the accumulation of mutant CALM protein.
  • Mutant CALM protein stabilization is a key mechanism driving severe cardiac phenotypes.
  • Allele dosage and protein stability significantly influence disease severity in calmodulinopathy.